NASDAQ:EYEN Eyenovia (EYEN) Stock Price, News & Analysis $0.48 +0.02 (+3.23%) (As of 10:46 AM ET) Add Compare Share Share Today's Range$0.45▼$0.4950-Day Range$0.47▼$1.4452-Week Range$0.37▼$2.57Volume2.57 million shsAverage Volume1.20 million shsMarket Capitalization$25.86 millionP/E RatioN/ADividend YieldN/APrice Target$10.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Eyenovia alerts: Email Address Eyenovia MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,050.5% Upside$10.00 Price TargetShort InterestHealthy5.03% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.49Based on 17 Articles This WeekInsider TradingAcquiring Shares$1 M Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($0.56) to ($0.67) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.25 out of 5 starsMedical Sector533rd out of 924 stocksPharmaceutical Preparations Industry241st out of 426 stocks 3.5 Analyst's Opinion Consensus RatingEyenovia has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEyenovia has only been the subject of 1 research reports in the past 90 days.Read more about Eyenovia's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted5.03% of the outstanding shares of Eyenovia have been sold short.Short Interest Ratio / Days to CoverEyenovia has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Eyenovia has recently decreased by 6.23%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEyenovia does not currently pay a dividend.Dividend GrowthEyenovia does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EYEN. Previous Next 2.5 News and Social Media Coverage News SentimentEyenovia has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Eyenovia this week, compared to 2 articles on an average week.Search Interest30 people have searched for EYEN on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Eyenovia to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Eyenovia insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,000,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 7.10% of the stock of Eyenovia is held by insiders.Percentage Held by InstitutionsOnly 25.84% of the stock of Eyenovia is held by institutions.Read more about Eyenovia's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Eyenovia are expected to decrease in the coming year, from ($0.56) to ($0.67) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Eyenovia is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Eyenovia is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEyenovia has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Eyenovia's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThis technology could swing the electionHidden in America's forgotten towns, a groundbreaking energy discovery is taking shape. And it's happening right in our own backyard - in the heart of Appalachia.Don't be left in the dark – watch now. About Eyenovia Stock (NASDAQ:EYEN)Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.Read More EYEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EYEN Stock News HeadlinesAugust 21 at 8:37 PM | markets.businessinsider.comEyenovia Prices 12.85 Mln Shares At $0.40/Share; Stock TanksAugust 21 at 8:37 PM | msn.comWhy Eyenovia (EYEN) Stock Is Getting Hammered TodayAugust 22, 2024 | Porter & Company (Ad)We recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…August 21 at 9:29 AM | globenewswire.comEyenovia Announces Pricing of $5.14 Million Public OfferingAugust 20 at 5:09 PM | globenewswire.comEyenovia, Inc. Announces Proposed Public OfferingAugust 20 at 8:16 AM | americanbankingnews.comShort Interest in Eyenovia, Inc. (NASDAQ:EYEN) Drops By 6.2%August 16, 2024 | ca.finance.yahoo.comEyenovia, Inc. (EYEN) Latest Stock News & Headlines - Yahoo FinanceAugust 16, 2024 | americanbankingnews.comEyenovia, Inc. Forecasted to Post Q3 2024 Earnings of ($0.14) Per Share (NASDAQ:EYEN)August 22, 2024 | Porter & Company (Ad)We recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…August 15, 2024 | finanznachrichten.deEyenovia, Inc.: Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | americanbankingnews.comQ3 2024 Earnings Forecast for Eyenovia, Inc. Issued By HC Wainwright (NASDAQ:EYEN)August 15, 2024 | americanbankingnews.comAnalysts Set Expectations for Eyenovia, Inc.'s Q3 2024 Earnings (NASDAQ:EYEN)August 15, 2024 | americanbankingnews.comFY2028 EPS Estimates for Eyenovia, Inc. Cut by Brookline Capital Management (NASDAQ:EYEN)August 15, 2024 | americanbankingnews.comBrokers Offer Predictions for Eyenovia, Inc.'s Q1 2025 Earnings (NASDAQ:EYEN)August 14, 2024 | americanbankingnews.comEyenovia's (EYEN) Buy Rating Reaffirmed at HC WainwrightAugust 14, 2024 | msn.comEyenovia, Inc. (NASDAQ:EYEN) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | finance.yahoo.comEyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceAugust 13, 2024 | seekingalpha.comEyenovia, Inc. (EYEN) Q2 2024 Earnings Call TranscriptSee More Headlines Receive EYEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eyenovia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today8/21/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:EYEN CUSIPN/A CIK1682639 Webwww.eyenoviabio.com Phone(917) 289-1117FaxN/AEmployees40Year FoundedN/APrice Target and Rating Average Stock Price Target$10.00 High Stock Price Target$12.00 Low Stock Price Target$8.00 Potential Upside/Downside+2,050.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,260,000.00 Net MarginsN/A Pretax Margin-360,488.88% Return on Equity-322.68% Return on Assets-100.51% Debt Debt-to-Equity Ratio3.72 Current Ratio0.88 Quick Ratio0.66 Sales & Book Value Annual Sales$31,405.00 Price / Sales797.64 Cash FlowN/A Price / Cash FlowN/A Book Value$0.20 per share Price / Book2.33Miscellaneous Outstanding Shares53,871,000Free Float50,046,000Market Cap$25.05 million OptionableOptionable Beta1.77 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Tsontcho Ianchulev M.D. (Age 50)M.P.H., MPH, Co-Founder & Executive Chairman Comp: $167.5kMr. Michael M. Rowe (Age 62)CEO & Director Comp: $775.47kMr. John P. Gandolfo CPA (Age 63)CFO & Secretary Comp: $578.15kMr. Bren Kern (Age 43)COO & Corporate VP Comp: $415.58kAlexander LoboInvestor ContactKey CompetitorsMarker TherapeuticsNASDAQ:MRKRLifecore BiomedicalNASDAQ:LFCRRezoluteNASDAQ:RZLT23andMeNASDAQ:MEGeneration BioNASDAQ:GBIOView All CompetitorsInsiders & InstitutionsSkyView Investment Advisors LLCBought 146,071 shares on 8/16/2024Ownership: 0.271%Armistice Capital LLCBought 6,060,606 shares on 8/15/2024Ownership: 11.250%Point72 Asia Singapore Pte. Ltd.Bought 43,784 shares on 8/15/2024Ownership: 0.081%Ground Swell Capital LLCBought 45,258 shares on 8/8/2024Ownership: 0.084%Nations Financial Group Inc. IA ADVBought 10,000 shares on 7/29/2024Ownership: 0.094%View All Insider TransactionsView All Institutional Transactions EYEN Stock Analysis - Frequently Asked Questions How have EYEN shares performed this year? Eyenovia's stock was trading at $2.08 on January 1st, 2024. Since then, EYEN shares have decreased by 77.6% and is now trading at $0.4650. View the best growth stocks for 2024 here. How were Eyenovia's earnings last quarter? Eyenovia, Inc. (NASDAQ:EYEN) posted its quarterly earnings results on Monday, March, 18th. The company reported ($0.17) EPS for the quarter, meeting the consensus estimate of ($0.17). When did Eyenovia IPO? Eyenovia (EYEN) raised $30 million in an initial public offering (IPO) on Thursday, January 25th 2018. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners acted as the underwriters for the IPO. Who are Eyenovia's major shareholders? Top institutional investors of Eyenovia include Armistice Capital LLC (11.25%), SkyView Investment Advisors LLC (0.27%), Nations Financial Group Inc. IA ADV (0.09%) and Ground Swell Capital LLC (0.08%). Insiders that own company stock include Stuart M Grant, Tsontcho Ianchulev, Charles E Iv Mather, Ellen R Strahlman, Michael M Rowe and Bren Kern. View institutional ownership trends. How do I buy shares of Eyenovia? Shares of EYEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Eyenovia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Eyenovia investors own include Sorrento Therapeutics (SRNE), OPKO Health (OPK), Vaxart (VXRT), Axsome Therapeutics (AXSM), Aldeyra Therapeutics (ALDX), Leap Therapeutics (LPTX) and Trevena (TRVN). This page (NASDAQ:EYEN) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyenovia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EYEN Stock Alerts